DJIA 18,010.68 -115.44 -0.64%
NASDAQ 5,070.03 -27.95 -0.55%
S&P 500 2,107.39 -13.40 -0.63%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

43.09 -0.07 (-0.16%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SGEN $43.09 -0.16%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $43.05
Previous Close $43.16
Daily Range $42.82 - $43.90
52-Week Range $30.05 - $44.95
Market Cap $5.4B
P/E Ratio -65.39
Dividend (Yield) $0.00 (0.0%)
Volume 782,363
Average Daily Volume 1,209,151
Current FY EPS -$0.76

Sector

Healthcare

Industry

Drug Makers

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website: http://www.seattlegenetics.com/

News & Commentary

Is This Why the Street Keeps Doubting Gilead Sciences, Inc.?

Gilead Sciences looks like a screaming buy right now based on its fundamentals. But the Street apparently doesn't think so. Here's why.

Seattle Genetics Larger Than S&P 500 Component Tenet Healthcare

Seattle Genetics Announces Clinical Data Presentations from Multiple Antibody-Drug Conjugate Program

Seattle Genetics Announces Clinical Data Presentations from Multiple Antibody-Drug Conjugate Programs

4 Big Biotech Companies to Sell Now

Otonomy, Renren And Other Names To Watch Heading Into Next Week

Insiders keep on buying Macerich Co and Seattle Genetics

Trade-Ideas: Seattle Genetics (SGEN) Is Today's Post-Market Leader Stock

4 Momentem Stocks Breaking Out and Poised to Move Higher

First Week of July 17th Options Trading For Seattle Genetics (SGEN)

Insiders new buys : ZU, SGEN, MAC, SHLD, TBRA

Seattle Genetics (SGEN) in Focus: Stock Up 8.1% - Tale of the Tape

Seattle Genetics (SGEN) in Focus: Stock Up 8.1% - Tale of the Tape

See More SGEN News...

SGEN's Top Competitors

SGEN $43.09 (-0.16%)
Current stock: SGEN
AMGN $156.26 (-0.69%)
Current stock: AMGN
BIIB $396.99 (-0.78%)
Current stock: BIIB
CELG $114.44 (-0.43%)
Current stock: CELG